India Clamps Down on Banned Malaria Pills to Prevent Super-Resistant Parasites

India’s top drug regulator has ordered an urgent nationwide crackdown. The target is banned single-drug malaria pills. The order went to all state drug controllers on December 8.

This move aims to stop the clandestine sale of oral artemisinin-only formulations. Health officials say these pills, banned since 2009, dangerously accelerate drug resistance. They threaten India’s most effective malaria treatments.

Why a 16-Year-Old Ban Needs Reinforcing

The Drugs Controller General of India (DCGI) issued the fresh directive. It notes some producers are still selling these banned monotherapies. This violates World Health Organization (WHO) protocols.

Using artemisinin alone is a half-measure. It kills some parasites quickly but may not clear the infection fully. Survivors are the most resilient parasites, leading to “super-parasites.” This undermines the gold-standard combination therapies India relies on.

Safeguarding Progress in a Critical Fight

The crackdown is crucial for public health. According to the WHO World Malaria Report 2025, India bears most of the region’s malaria burden. The country saw an estimated 11% increase in cases from 2023 to 2024.

Despite progress, this uptick keeps officials alert. India has reduced malaria cases by over 78% since 2015. Protecting the efficacy of frontline drugs is key to sustaining this gain and achieving elimination by 2030.

India’s decisive action against banned malaria pills is a frontline defense. It protects vital medicines in the ongoing fight against a deadly disease.

Thought you’d like to know

Why is taking artemisinin alone so dangerous?

It often doesn’t stay in the body long enough for a full cure. The surviving parasites are the toughest ones. They can then create drug-resistant malaria strains.

What is the correct treatment for malaria?

Doctors use Artemisinin-based Combination Therapies (ACTs). These mix artemisinin with another drug. The combination delivers a complete cure the parasite cannot easily resist.

What are the penalties for making these banned pills?

Violations can lead to imprisonment for three years or more. Companies also face heavy fines and immediate cancellation of their manufacturing licenses.

Is malaria still a major problem in India?

Yes. India accounted for roughly 2 million estimated cases in 2024. It remains the epicentre of malaria in the WHO South-East Asia Region.

What has the WHO said about this move?

The WHO representative to India called the directive a vital public-health measure. It strengthens global control efforts and protects the long-term efficacy of life-saving ACTs.